Metraipolis › archive › dc_d7cf72deccbe

An Open-Label Randomized Controlled Trial Comparing the Efficacy and Safety of a 7-Day Triple Therapy With Bismuth Versus 14-Day Standard Triple Therapy for… — Europe PMC PMID:41498301

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41498301
DOI: 10.1111/hel.70103
License (as archived): solo-consultazione
Archived: 2026-11-07T05:45:15.756Z
SHA-256 of the archived text: d06f6ea38a4bae62290176b512afde7e9471a18650fe3fa701e6043ae125d507
Stable URL of this page: https://metraipolis.com/documento/dc_d7cf72deccbe

How to cite

An Open-Label Randomized Controlled Trial Comparing the Efficacy and Safety of a 7-Day Triple Therapy With Bismuth Versus 14-Day Standard Triple Therapy for… — Europe PMC PMID:41498301 — Europe PMC (en), https://europepmc.org/article/MED/41498301 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d7cf72deccbe (Metraipolis archive dc_d7cf72deccbe, sha256 d06f6ea38a4bae62290176b512afde7e9471a18650fe3fa701e6043ae125d507)

BibTeX

@misc{dcd7cf72deccbe,
  title = {An Open-Label Randomized Controlled Trial Comparing the Efficacy and Safety of a 7-Day Triple Therapy With Bismuth Versus 14-Day Standard Triple Therapy for… — Europe PMC PMID:41498301},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41498301},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d7cf72deccbe; sha256 d06f6ea38a4bae62290176b512afde7e9471a18650fe3fa701e6043ae125d507},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41498301. Agents can read the archived copy with the MCP tool read_document.